The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival.

Over the course of evolution, viruses have developed the ability to modulate a variety of host cell signalling pathways. Inhibition of apoptosis, in particular, has become recognized as an important contributory factor in virus survival. Apoptotic inhibition contributes to the establishment of latent and chronic infections and has been implicated in viral oncogenesis. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway is utilized by many cell types for inhibition of apoptosis and cellular survival. Virus modulation of this pathway provides an alternative to the expression of viral oncogenes or the direct inhibition of pro-apoptotic proteins. It has become evident that many viruses require up-regulation of this pathway to sustain long-term infections and it is modulated, in some cases, by specific viral products to create an environment favourable for cellular transformation. In other cases, PI3K-Akt signalling simply helps to create an environment favourable for virus replication and virion assembly. This review details the modulation and function of PI3K-Akt signalling for virus survival.

[1]  M. Birnbaum,et al.  Polyoma middle T antigen activates the Ser/Thr kinase Akt in a PI3-kinase-dependent manner. , 1998, Biochemical and biophysical research communications.

[2]  D. Spandau,et al.  E5 Protein of Human Papillomavirus Type 16 Protects Human Foreskin Keratinocytes from UV B-Irradiation-Induced Apoptosis , 2002, Journal of Virology.

[3]  R. Schneider,et al.  Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  E. Hwang,et al.  The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection , 1997, Journal of virology.

[5]  A. Velázquez,et al.  Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin. , 1997, Virology.

[6]  M. Waterfield,et al.  Synthesis and function of 3-phosphorylated inositol lipids. , 2001, Annual review of biochemistry.

[7]  J. Romashkova,et al.  NF-κB is a target of AKT in anti-apoptotic PDGF signalling , 1999, Nature.

[8]  D. Brenner,et al.  Akt protects mouse hepatocytes from TNF-α- and Fas-mediated apoptosis through NK-κB activation , 2001 .

[9]  S. Salahuddin,et al.  Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients , 1990, Nature.

[10]  C. Cheng‐Mayer,et al.  The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. , 1997, Immunity.

[11]  F. Su,et al.  Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases , 1996, Journal of virology.

[12]  J. Alwine,et al.  Human Cytomegalovirus Major Immediate-Early Proteins and Simian Virus 40 Large T Antigen Can Inhibit Apoptosis through Activation of the Phosphatidylinositide 3′-OH Kinase Pathway and the Cellular Kinase Akt , 2002, Journal of Virology.

[13]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[14]  C. Downes,et al.  PTEN: The down side of PI 3-kinase signalling. , 2002, Cellular signalling.

[15]  U. Georgopoulou,et al.  Suppression of the ERK1/2 signaling pathway from HCV NS5A protein expressed by herpes simplex recombinant viruses , 2003, Archives of Virology.

[16]  J. Hartley,et al.  Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[17]  T. Roberts,et al.  Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Woodgett,et al.  Unravelling the activation mechanisms of protein kinase B/Akt , 2003, FEBS letters.

[19]  D. Cantrell.  Phosphoinositide 3-kinase signalling pathways. , 2001, Journal of cell science.

[20]  M. Greaves,et al.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.

[21]  B. Peterlin,et al.  Interaction between Nef and phosphatidylinositol-3-kinase leads to activation of p21-activated kinase and increased production of HIV. , 2002, Virology.

[22]  J. McDougall,et al.  Immortalization of primary human epithelial cells by cloned cervical carcinoma DNA containing human papillomavirus type 16 E6/E7 open reading frames. , 1989, The Journal of general virology.

[23]  S. Do,et al.  The Hepatitis B Virus-X Protein Activates a Phosphatidylinositol 3-Kinase-dependent Survival Signaling Cascade* , 2001, The Journal of Biological Chemistry.

[24]  E. Kieff.  Epstein-Barr virus and its replication , 1996 .

[25]  John Calvin Reed,et al.  Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.

[26]  N. Cooper,et al.  Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. , 1998, Virology.

[27]  M. Brizzi,et al.  HIV-1-Tat Protein Activates Phosphatidylinositol 3-Kinase/ AKT-dependent Survival Pathways in Kaposi's Sarcoma Cells* , 2002, The Journal of Biological Chemistry.

[28]  B. Thomson,et al.  Viruses and apoptosis , 2001, International journal of experimental pathology.

[29]  E. Auvinen,et al.  The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT. , 1998, Experimental cell research.

[30]  J. Woodgett,et al.  Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. , 1991, European journal of biochemistry.

[31]  S. Kenney,et al.  Epstein-Barr Virus Immediate-Early Protein BRLF1 Induces the Lytic Form of Viral Replication through a Mechanism Involving Phosphatidylinositol-3 Kinase Activation , 2001, Journal of Virology.

[32]  C. Ware,et al.  The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family , 1995, Cell.

[33]  E. Cheng,et al.  A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. McMichael,et al.  Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. , 2001, Immunity.

[35]  M. Moon,et al.  Coxsackievirus B3 Induces Apoptosis in the Early Phase of Murine Myocarditis: A Comparative Analysis of Cardiovirulent and Noncardiovirulent Strains , 2003, Intervirology.

[36]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[37]  J. Dixon,et al.  PTEN: a tumour suppressor that functions as a phospholipid phosphatase. , 1999, Trends in cell biology.

[38]  B. McManus,et al.  Overexpression of Interferon-γ-inducible GTPase Inhibits Coxsackievirus B3-induced Apoptosis through the Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway and Inhibition of Viral Replication* , 2003, Journal of Biological Chemistry.

[39]  J. Doorbar,et al.  Human Papillomaviruses , 2006, Methods in Molecular Medicine.

[40]  M. Katze,et al.  NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  W. Liu,et al.  Association of Polyomavirus Middle Tumor Antigen with Phospholipase C-γ1(*) , 1995, The Journal of Biological Chemistry.

[42]  G. Cooper,et al.  Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway* , 1998, The Journal of Biological Chemistry.

[43]  D. Noonan,et al.  HIV-tat protein is a heparin-binding angiogenic growth factor. , 1996, Oncogene.

[44]  M. Waterfield,et al.  Signaling by distinct classes of phosphoinositide 3-kinases. , 1999, Experimental cell research.

[45]  Francis Simon,et al.  Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3. , 2002, Biochimica et biophysica acta.

[46]  P. Tsichlis,et al.  AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. , 1999, Annual review of biochemistry.

[47]  R. Garofalo,et al.  Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. , 2002, The Journal of infectious diseases.

[48]  M. Klotman,et al.  Phosphatidylinositol 3-Kinase Regulates Human Immunodeficiency Virus Type 1 Replication following Viral Entry in Primary CD4+ T Lymphocytes and Macrophages , 2003, Journal of Virology.

[49]  Yi-Hsien Su,et al.  Suppression of transforming growth factor-β-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway , 1998, Oncogene.

[50]  T. Benjamin,et al.  Evidence of a Role for Phosphatidylinositol 3-Kinase Activation in the Blocking of Apoptosis by Polyomavirus Middle T Antigen , 1998, Journal of Virology.

[51]  P. Moore,et al.  Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS. , 1996, Infectious agents and disease.

[52]  P. Wingfield,et al.  Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation , 1993, Journal of virology.

[53]  S. Huong,et al.  Human Cytomegalovirus Up-Regulates the Phosphatidylinositol 3-Kinase (PI3-K) Pathway: Inhibition of PI3-K Activity Inhibits Viral Replication and Virus-Induced Signaling , 2001, Journal of Virology.

[54]  R. Lockey,et al.  Respiratory syncytial virus infection activates STAT signaling in human epithelial cells. , 2003, Biochemical and biophysical research communications.

[55]  M. Tremblay,et al.  Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase. , 1997, Virology.

[56]  E. Cesarman,et al.  Erratum: G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.

[57]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[58]  E. Kieff,et al.  The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential , 1992, Journal of virology.

[59]  P. Cohen,et al.  Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B* , 1999, The Journal of Biological Chemistry.

[60]  M. Katze,et al.  Subversion of Cell Signaling Pathways by Hepatitis C Virus Nonstructural 5A Protein via Interaction with Grb2 and P85 Phosphatidylinositol 3-Kinase , 2002, Journal of Virology.

[61]  D. DiMaio,et al.  The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. , 1995, Virology.

[62]  L. Cantley,et al.  Phosphatidylinositol metabolism and polyoma-mediated transformation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. McCubrey,et al.  Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy , 2003, Leukemia.

[64]  T. Shenk,et al.  Human cytomegalovirus IE1 and IE2 proteins block apoptosis. , 1995, Journal of virology.

[65]  M. Gold,et al.  Targets of B‐cell antigen receptor signaling: the phosphatidylinositol 3‐kinase/Akt/glycogen synthase kinase‐3 signaling pathway and the Rap1 GTPase , 2000, Immunological reviews.

[66]  L. Young,et al.  Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) Activates the Phosphatidylinositol 3-Kinase/Akt Pathway to Promote Cell Survival and Induce Actin Filament Remodeling* , 2003, The Journal of Biological Chemistry.

[67]  S. Kenney,et al.  Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[68]  L. Pfeffer,et al.  Interferon α/β Promotes Cell Survival by Activating Nuclear Factor κB through Phosphatidylinositol 3-Kinase and Akt* , 2001, The Journal of Biological Chemistry.

[69]  B. Hemmings,et al.  Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[70]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[71]  P. Lazo.  Pathogenesis of viral infections. , 1985, The New England journal of medicine.

[72]  E. Kieff,et al.  The Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 Engages the Tumor Necrosis Factor Receptor-Associated Proteins TRADD and Receptor-Interacting Protein (RIP) but Does Not Induce Apoptosis or Require RIP for NF-κB Activation , 1999, Molecular and Cellular Biology.

[73]  V. Arora,et al.  Nef: agent of cell subversion. , 2002, Microbes and infection.

[74]  G. Panayotou,et al.  Phospholipid-binding protein domains. , 1998, Biochimica et biophysica acta.

[75]  H. Hausen.  Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.

[76]  B. McManus,et al.  Caspase Activation and Specific Cleavage of Substrates after Coxsackievirus B3-Induced Cytopathic Effect in HeLa Cells , 1998, Journal of Virology.

[77]  Shinn-Jang Hwang,et al.  HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis , 2002, Oncogene.

[78]  C. Boshoff,et al.  Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV , 1996, Science.

[79]  J. Sinnott,et al.  Respiratory Syncytial Virus , 1988, Infection Control & Hospital Epidemiology.

[80]  John N. Hutchinson,et al.  Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis , 1998, Molecular and Cellular Biology.

[81]  M. Ueffing,et al.  Latent membrane protein 1 of Epstein–Barr virus mimics a constitutively active receptor molecule , 1997, The EMBO journal.

[82]  M. Kuo,et al.  Hepatitis B Virus X Protein Inhibits Transforming Growth Factor-β-induced Apoptosis through the Activation of Phosphatidylinositol 3-Kinase Pathway* , 2000, The Journal of Biological Chemistry.

[83]  R. A. Johnson,et al.  The role of MKK1/2 kinase activity in human cytomegalovirus infection. , 2001, The Journal of general virology.

[84]  M Geyer,et al.  Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. , 1999, Molecular cell.

[85]  Ying Sun,et al.  The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.

[86]  A. Dalgleish,et al.  Kaposi's sarcoma. , 1991, British Journal of Cancer.

[87]  B. McManus,et al.  Viral myocarditis: identification of five differentially expressed genes in coxsackievirus B3-infected mouse heart. , 1999, Circulation research.

[88]  K. M. Bendt,et al.  Epstein-Barr Virus LMP2A Transforms Epithelial Cells, Inhibits Cell Differentiation, and Activates Akt , 2000, Journal of Virology.

[89]  L. Cantley,et al.  Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation , 1985, Nature.

[90]  Tomohiko Maehama,et al.  The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.

[91]  W. Bresnahan,et al.  Human cytomegalovirus infection results in altered Cdk2 subcellular localization. , 1997, The Journal of general virology.

[92]  D. Lowy,et al.  HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. , 1989, The EMBO journal.

[93]  B. Vanhaesebroeck,et al.  The PI3K-PDK1 connection: more than just a road to PKB. , 2000, The Biochemical journal.

[94]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[95]  R. Medema,et al.  Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty , 2003, Journal of leukocyte biology.

[96]  J. Testa,et al.  A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. , 1991, Science.

[97]  L. Villarreal,et al.  Natural Biology of Polyomavirus Middle T Antigen , 2001, Microbiology and Molecular Biology Reviews.

[98]  M. Ueffing,et al.  Latent membrane protein 1 of Epstein–Barr virus interacts with JAK3 and activates STAT proteins , 1999, The EMBO journal.

[99]  R. Schlegel,et al.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes , 1989, Journal of virology.

[100]  S. Murakami.  Hepatitis B Virus X Protein: Structure, Function and Biology , 1999, Intervirology.

[101]  E. Cesarman,et al.  G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.

[102]  J. Sample,et al.  Latent Membrane Protein 2A-Mediated Effects on the Phosphatidylinositol 3-Kinase/Akt Pathway , 2000, Journal of Virology.

[103]  A. Schürmann,et al.  HIV-1 Nef associated PAK and PI3-Kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals , 2001, Nature Medicine.

[104]  G. Hunninghake,et al.  Respiratory Syncytial Virus Inhibits Apoptosis and Induces NF-κB Activity through a Phosphatidylinositol 3-Kinase-dependent Pathway* , 2002, The Journal of Biological Chemistry.

[105]  E. Kieff,et al.  An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[106]  N Enomoto,et al.  Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. , 1996, The New England journal of medicine.

[107]  R. Gallo.  The Enigmas of Kaposi's Sarcoma , 1998, Science.

[108]  R. Longnecker,et al.  Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus. , 1999, The Journal of general virology.

[109]  E. Huang,et al.  Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters , 1997, Journal of virology.

[110]  A. Klippel,et al.  Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt , 1997, Molecular and cellular biology.

[111]  M. Kuo,et al.  Hepatitis B Virus X Protein Activates a Survival Signaling by Linking Src to Phosphatidylinositol 3-Kinase* , 2003, Journal of Biological Chemistry.

[112]  L. Pfeffer,et al.  NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.

[113]  A. Albini,et al.  HIV type 1 Tat protein is a survival factor for Kaposi's sarcoma and endothelial cells. , 2001, AIDS research and human retroviruses.

[114]  S. Huong,et al.  Activation of the Mitogen-Activated Protein Kinase p38 by Human Cytomegalovirus Infection through Two Distinct Pathways: a Novel Mechanism for Activation of p38 , 2000, Journal of Virology.

[115]  L. Young,et al.  Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) , 1998, Oncogene.

[116]  E. Flemington,et al.  Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c-fos , 1990, Journal of virology.

[117]  U. Nater,et al.  Epstein-Barr virus. , 1991, The Journal of family practice.

[118]  Asim Khwaja,et al.  Apoptosis: Akt is more than just a Bad kinase , 1999, Nature.

[119]  W. Greene,et al.  HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell , 2001, Nature.

[120]  N. Hay,et al.  Akt, a Target of Phosphatidylinositol 3-Kinase, Inhibits Apoptosis in a Differentiating Neuronal Cell Line , 1998, Molecular and Cellular Biology.